Max Planck Institute of Molecular Biomedicine, Münster, Germany; and.
Institute of Resource Development and Analysis, Kumamoto University, Kumamoto, Japan.
Blood. 2017 Mar 30;129(13):1811-1822. doi: 10.1182/blood-2016-08-733394. Epub 2017 Feb 21.
CD99 is a crucial regulator of the transmigration (diapedesis) of leukocytes through the blood vessel wall. Here, we report that CD99 acts at 2 different steps in the extravasation process. In agreement with previous antibody-blocking experiments, we found that CD99 gene inactivation caused neutrophil accumulation between venular endothelial cells and the basement membrane in the inflamed cremaster. Unexpectedly, we additionally found that leukocyte attachment to the luminal surface of the venular endothelium was impaired in the absence of CD99. Intravital video microscopy revealed that CD99 supported rapid chemokine-induced leukocyte arrest. Inhibition of leukocyte attachment and extravasation were both solely due to the absence of CD99 on endothelial cells, whereas CD99 on leukocytes was irrelevant. Therefore, we searched for heterophilic ligands of endothelial CD99 on neutrophils. We found that endothelial cells bind to the paired immunoglobulinlike receptors (PILRs) in a strictly CD99-dependent way. In addition, endothelial CD99 was coprecipitated with PILRs from neutrophils that adhered to endothelial cells. Furthermore, soluble CD99 carrying a transferable biotin tag could transfer this tag covalently to PILR when incubated with intact neutrophils. Binding of neutrophils under flow to a surface coated with P-selectin fragment crystallizable (Fc) and intercellular adhesion molecule 1 (ICAM-1) Fc became more shear resistant if CD99 Fc was coimmobilized. This increased shear resistance was lost if neutrophils were preincubated with anti-PILR antibodies. We concluded that endothelial CD99 promotes leukocyte attachment to endothelium in inflamed vessels by a heterophilic ligand. In addition, CD99 binds to PILRs on neutrophils, an interaction that leads to increased shear resistance of the neutrophil attachment to ICAM-1.
CD99 是白细胞穿越血管壁迁移(出芽)的关键调节因子。在这里,我们报告 CD99 在血管外渗过程中的 2 个不同步骤中起作用。与之前的抗体阻断实验一致,我们发现 CD99 基因失活导致中性粒细胞在炎症性精索内静脉内皮细胞和基底膜之间积聚。出乎意料的是,我们还发现,在缺乏 CD99 的情况下,白细胞与静脉内皮细胞管腔表面的附着受到损害。活体视频显微镜显示,CD99 支持快速趋化因子诱导的白细胞捕获。白细胞附着和血管外渗的抑制都仅仅是由于内皮细胞上缺乏 CD99,而白细胞上的 CD99 无关紧要。因此,我们在中性粒细胞上寻找内皮细胞 CD99 的异嗜性配体。我们发现内皮细胞以严格依赖 CD99 的方式与配对免疫球蛋白样受体(PILR)结合。此外,与内皮细胞附着的中性粒细胞的 PILR 一起共沉淀了内皮细胞 CD99。此外,当与完整的中性粒细胞孵育时,携带可转移生物素标记的可溶性 CD99 可以将该标记共价转移到 PILR 上。如果共固定 CD99Fc,则在流动条件下,中性粒细胞对涂有 P 选择素片段结晶(Fc)和细胞间黏附分子 1(ICAM-1)Fc 的表面的结合对剪切力的抵抗力增加。如果预先用抗 PILR 抗体孵育中性粒细胞,则会失去这种增加的剪切力抵抗力。我们得出结论,内皮细胞 CD99 通过异嗜性配体促进炎症血管中白细胞与内皮的附着。此外,CD99 与中性粒细胞上的 PILR 结合,这种相互作用导致中性粒细胞与 ICAM-1 的附着对剪切力的抵抗力增加。